Literature DB >> 26724277

Vitiligo: Pathogenesis, clinical variants and treatment approaches.

Giannicola Iannella1, Antonio Greco2, Dario Didona3, Biagio Didona4, Guido Granata5, Alessandra Manno6, Benedetta Pasquariello7, Giuseppe Magliulo8.   

Abstract

Vitiligo is a common chronic acquired disease of pigmentation whose etiology is unknown, which usually occurs with asymptomatic whitish patch or macule. Although several hypotheses have been proposed in the literature, the leading theory is still the auto-immune etiology linked to specific genetic mutations. Vitiligo can also be associated with several autoimmune diseases, including autoimmune thyroid diseases, alopecia areata, and halo nevi. Sensorineural hearing loss was reported in several vitiligo patients due to a reduction in the number of melanocytes contained in the membranous labyrinth of the inner ear. Because of its complexity, several therapeutic options are available to treat this systemic disease.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autoimmune diseases; Hearing loss; NB-UVB; Oxidative stress; Prednisolone; Vitiligo

Mesh:

Year:  2015        PMID: 26724277     DOI: 10.1016/j.autrev.2015.12.006

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  33 in total

1.  Evaluation of dry eye and meibomian gland dysfunction with meibography in vitiligo.

Authors:  M Palamar; P Kiyat; I Ertam; A Yagci
Journal:  Eye (Lond)       Date:  2017-03-10       Impact factor: 3.775

2.  [Vitiligo and psoriasis : An underdiagnosed coincidence?]

Authors:  A-K Dumke; P Elsner; S Goetze
Journal:  Hautarzt       Date:  2018-07       Impact factor: 0.751

3.  Incident alopecia areata and vitiligo in adult women with atopic dermatitis: Nurses' Health Study 2.

Authors:  A M Drucker; J M Thompson; W-Q Li; E Cho; T Li; E Guttman-Yassky; A A Qureshi
Journal:  Allergy       Date:  2017-02-06       Impact factor: 13.146

4.  In Vitro TyRP-1 Knockdown Based on siRNA Carried by Liquid Crystalline Nanodispersions: an Alternative Approach for Topical Treatment of Vitiligo.

Authors:  Larissa Bueno Tofani; Lívia Vieira Depieri; Patrícia Mazureki Campos; Thalita Bachelli Riul; Kamilla Swiech Antonietto; Márcia Carvalho de Abreu Fantini; Maria Vitória Lopes Badra Bentley
Journal:  Pharm Res       Date:  2018-03-20       Impact factor: 4.200

5.  Anatomically distinct fibroblast subsets determine skin autoimmune patterns.

Authors:  Zijian Xu; Daoming Chen; Yucheng Hu; Kaiju Jiang; Huanwei Huang; Yingxue Du; Wenbo Wu; Jiawen Wang; Jianhua Sui; Wenhui Wang; Long Zhang; Shuli Li; Chunying Li; Yong Yang; Jianmin Chang; Ting Chen
Journal:  Nature       Date:  2021-12-15       Impact factor: 49.962

Review 6.  Dysfunction of Autophagy: A Possible Mechanism Involved in the Pathogenesis of Vitiligo by Breaking the Redox Balance of Melanocytes.

Authors:  Zhuhui Qiao; Xiuxiu Wang; Leihong Xiang; Chengfeng Zhang
Journal:  Oxid Med Cell Longev       Date:  2016-11-29       Impact factor: 6.543

Review 7.  Paraneoplastic Pemphigus: Insight into the Autoimmune Pathogenesis, Clinical Features and Therapy.

Authors:  Giovanni Paolino; Dario Didona; Giuseppe Magliulo; Giannicola Iannella; Biagio Didona; Santo Raffaele Mercuri; Elisa Moliterni; Michele Donati; Andrea Ciofalo; Guido Granata; Patricia Ranuzzi; Vincenzo Falasca; Stefano Calvieri
Journal:  Int J Mol Sci       Date:  2017-11-26       Impact factor: 5.923

Review 8.  Updates and new medical treatments for vitiligo (Review).

Authors:  David Emmanuel Kubelis-López; Natalia Aranza Zapata-Salazar; Salvador Luis Said-Fernández; Celia Nohemí Sánchez-Domínguez; Mauricio Andrés Salinas-Santander; Herminia Guadalupe Martínez-Rodríguez; Osvaldo Tomás Vázquez-Martínez; Uwe Wollina; Torello Lotti; Jorge Ocampo-Candiani
Journal:  Exp Ther Med       Date:  2021-05-25       Impact factor: 2.447

Review 9.  The Development of Sugar-Based Anti-Melanogenic Agents.

Authors:  Bum-Ho Bin; Sung Tae Kim; Jinhyuk Bhin; Tae Ryong Lee; Eun-Gyung Cho
Journal:  Int J Mol Sci       Date:  2016-04-16       Impact factor: 5.923

Review 10.  Current Perspectives on Severe Drug Eruption.

Authors:  Jingzhan Zhang; Zixian Lei; Chen Xu; Juan Zhao; Xiaojing Kang
Journal:  Clin Rev Allergy Immunol       Date:  2021-07-17       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.